Key facts
- This page summarizes Ulo Palm's Form 4 filing for Vaxxinity, Inc..
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 15 Mar 2022, 20:56.
Ulo Palm - 15 Mar 2022 Form 4 Insider Report for Vaxxinity, Inc.
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- N/A
- Reported as of
- 15 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Mar 2022, 20:56:36 UTC
- Prior SEC filing
- 15 Nov 2021
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- Rene Paula Molina, attorney-in-fact for Ulo Palm
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Ulo Palm filed Form 4 for Vaxxinity, Inc. on 15 Mar 2022.
Change
- Previous filing in this sequence was filed on 15 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VAXX
holding
Class A common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 450
- Date
- 15 Mar 2022
- Ownership
- Held by spouse
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VAXX
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 15 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
- 100,000
- Exercise price
- Footnotes
- F2, F3
VAXX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 233,100
- Date
- 15 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
- 233,100
- Exercise price
- $13.00
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These securities are held by Kathrin Palm, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kathrin Palm in which the Reporting Person has no pecuniary interest.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A common stock.
Footnote F3
The Reporting Person received restricted stock units subject to a four-year vesting schedule, vesting 100% on March 15, 2026, subject to the Reporting Person's continued employment with the Issuer through the vesting date. The restricted stock units do not expire but are settled in shares of Class A common stock as soon as practicable after the vesting date.
Footnote F4
These options are subject to a four-year time-vesting schedule, with 25% vesting on November 11, 2022 and the remainder vesting in equal installments each month during the remainder of the vesting schedule, subject to the Reporting Person's continued employment with the Issuer through the vesting date.